Canopy Growth Acquires Germany’s C3 Cannabinoid Compound Company

C3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in Germany , Austria , Switzerland , and Denmark . Dronabinol was the first cannabinoid product in Germany that could be prescribed by the country’s physicians. In 2018, C3 supplied approximately 19,500 patients in Germany with dronabinol, achieving a YOY increase of 85%.

READ MORE: https://finance.yahoo.com/news/canopy-growth-acquires-germanys-c3-110000835.html?.tsrc=rss